Kenneth W. O'Keefe, Director at Jazz Pharmaceuticals plc (JAZZ), sold 600,000 shares at $49.56 ($29.7M) on 2012-03-09, disclosed to the SEC on 2012-03-13.
Open-market sale of $29.7M JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |
| JAZZ | SELL | 2020-11-09 | $3.4M | — | Filing → |